{{Rsnum
|rsid=2770150
|Chromosome=9
|position=117700861
|Orientation=plus
|GMAF=0.1515
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 38.1 | 52.2
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 19.7 | 80.3
| ASW | 0.0 | 19.3 | 80.7
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.9 | 99.1
| GIH | 7.9 | 37.6 | 54.5
| LWK | 1.8 | 22.7 | 75.5
| MEX | 10.3 | 27.6 | 62.1
| MKK | 5.1 | 23.1 | 71.8
| TSI | 4.9 | 35.3 | 59.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20685742
|Title=Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma
}}

{{PMID Auto
|PMID=17699831
|Title=Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.
|OA=1
}}

{{PMID Auto
|PMID=18298826
|Title=Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol.
|OA=1
}}

{{PMID Auto
|PMID=18549840
|Title=Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke.
|OA=1
}}

{{PMID Auto
|PMID=18987746
|Title=Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination.
|OA=1
}}

{{PMID Auto
|PMID=20200442
|Title=Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}